Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Superselective Ophthalmic Artery Interventional Chemotherapy for Intraocular Retinoblastoma

NCT05028270 is registered in ClinicalTrials.gov with Xinhua Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT05028270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Superselective Ophthalmic Artery Interventional Chemotherapy for Intraocular Retinoblastoma
Lead sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Overall status
Unknown status
Start date
June 20, 2022
Completion date
August 1, 2023
Enrollment
1,600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma